Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3057% above fair value
$3.80−0.29 (-7.09%)
Close on Nov 13, 2026Market cap $238.46MP/E –Yield 0.00%
Camp4 Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Camp4 Therapeutics's total assets was $134.01M at Sep 30, 2026. For fiscal 2025 it was $117.81M, up 50.4% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $117.81M | +50.4% |
| FY2024 | Dec 31, 2024 | $78.31M | +42.5% |
| FY2023 | Dec 31, 2023 | $54.95M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $134.01M | +55.1% |
| Q2 FY2026 | Jun 30, 2026 | $93.43M | +82.2% |
| Q1 FY2026 | Mar 31, 2026 | $105.46M | +68.0% |
| Q4 FY2025 | Dec 31, 2025 | $117.81M | +50.4% |
| Q3 FY2025 | Sep 30, 2025 | $86.40M | +304.4% |
| Q2 FY2025 | Jun 30, 2025 | $51.28M | -6.7% |
| Q1 FY2025 | Mar 31, 2025 | $62.77M | – |
| Q4 FY2024 | Dec 31, 2024 | $78.31M | – |
| Q3 FY2024 | Sep 30, 2024 | $21.36M | – |
| Q4 FY2023 | Dec 31, 2023 | $54.95M | – |
See a number that looks wrong?